3,122
Views
11
CrossRef citations to date
0
Altmetric
Review

Epidemiology and evolution of Norovirus in China

, , , , , & show all
Pages 4553-4566 | Received 19 Mar 2021, Accepted 21 Jul 2021, Published online: 08 Sep 2021

References

  • Hemming M, Räsänen S, Huhti L, Paloniemi M, Salminen M, Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr. 2013;172:739–46. doi:10.1007/s00431-013-1945-3.
  • Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, Parashar UD, Koopmans M, Lopman BA. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:725–30. doi:10.1016/S473-3099(14)70767-4.
  • Pires SM, Fischer-Walker CL, Lanata CF, Brecht D, Hall AJ, Kirk MD, Duarte ASR, Black RE, Angulo FJ. Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food. Plos One. 2015;10:e0142927. doi:10.1371/journal.pone.0142927.
  • GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18:1211–28. doi:10.1016/S473-3099(18)30362-1.
  • Bartsch SM, Lopman BA, Sachiko O, Hall AJ, Lee BY. Global economic burden of Norovirus gastroenteritis. Plos One. 2016;11:e0151219. doi:10.1371/journal.pone.0151219.
  • Todd K, Tripp R. Human Norovirus: experimental models of infection. Viruses. 2019;11:151. doi:10.3390/v11020151.
  • Chi-Wai CM, Kirsty K, Lin-Yao Z, Mohammad KN, Nelson L, Lui GCY, Nelson EAS, Lai RWM, Leung TF, Chan PKS, et al. Bimodal seasonality and alternating predominance of Norovirus GII.4 and Non-GII.4, Hong Kong, China, 2014–2017. Emerg Infect Dis. 2018;24:767–69. doi:10.3201/eid2404.171791.
  • Vinjé J, Doern GV. Advances in laboratory methods for detection and typing of Norovirus. J Clin Microbiol. 2015;53:373–81. doi:10.1128/JCM.01535-14.
  • Mans J. Norovirus infections and disease in Lower-MiddleandLow-Income Countries, 1997-2018. Viruses. 2019;11:341. doi:10.3390/v11040341.
  • Phillips G, Tam CC, Rodrigues LC, Lopman B. Risk factors for symptomatic and asymptomatic norovirus infection in the community. Epidemiol Infect. 2011;139:1676–86. doi:10.1017/S0950268810002839.
  • Phillips G, Tam CC, Conti S, Rodrigues LC, Brown D, Iturriza-Gomara M, Gray J, Lopman B. Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis. Am J Epidemiol. 2010;171:1014–22. doi:10.93/aje/kwq021.
  • Mans J, Armah GE, Steele AD, Taylor MB. Norovirus Epidemiology in Africa: a Review. PLoS One. 2016;11:e0146280. doi:10.1371/journal.pone.0146280.
  • Garcı´a C, DuPont HL, Long KZ, Santos JI, Ko G. Asymptomatic norovirus infection in Mexican children. J Clin Microbiol. 2006;44:2997–3000. doi:10.1128/JCM.00065-06.
  • Lin YX, Wei QD, Feng R, Zang LR. Genotypes of norovirus in Zhuhai region, 2011-2013. Pract Prev Med. 2017;24:364–68. (in Chinese). doi:10.3969/j.1006-3110.2017.03.032.
  • Cao YN, Zhang XJ, Chen N. Epidemiological surveillance of norovirus and rotavirus in children with diarrhea. J Pub Health Prev Med. 2020;31:42–44. (in Chinese).
  • Fang YL, Wang W, Wang P, Zhao Y, Zhang TQ, Li X, et al. Molecular epidemiology of norovirus in children with acute gastroenteritis in Tianjin, China. Chin J Contemp Pediatr. 2019;21:139–43. (in Chinese). doi:10.7499/j.1008-8830.2019.02.006.
  • Liao Y, Chen JH, Liu ZY, Peng Z, et al. The characterization of norovirus genotypes in children in Chongqing. J Chongqing Med Univ. 2011;36:242–45. (in Chinese). doi:10.13406/j.cnki.cyxb.2011.02.001.
  • Fu JG, Ai J, Zhang J, Wu QB, Qi X. Molecular epidemiology of genogroup II norovirus infection among hospitalized children with acute gastroenteritis in Suzhou (Jiangsu, China) from 2010 to 2013. J Med Virol. 2015;88:954–60. doi:10.1002/jmv.24429.
  • Fu JG, Ai J, Qi X, Zhang J, Tang FY, Zhu YF. Emergence of two novel norovirus genotype II.4 variants associated with viral gastroenteritis in China. J Med Virol. 2014;86:1226–34. doi:10.002/jmv.23799.
  • Yao WL, Cai JH, Wang XS, Ge YL, Zhu QR, Zeng M. Surveillance of norovirus-associated diarrhea in children in Shanghai, 2009-2011. Chin J Pediatr. 2014;52:339–44. doi:10.3760/cma.j.0578-1310.2014.05.005.
  • Chen ZH, Huang GL, Chen XL. Molecular epidemiological study on norovirus in infants with diarrhea in Xiamen. Maternal Child Health Care China. 2012;27:5312–14. (in Chinese).
  • Zhang Y, Chen Y, Liu Z, Zhang Y. Acute diarchea in children in Yinchuan: etiology and related factors. World Chin J Digestol. 2015;23:2975–80. (in Chinese). doi:10.11569/wcjd.v23.i18.2975.
  • Shen JC, Liu YF, Xie HP. Genotyping study of Novovirus infection in clinic children under 5 years in Guangzhou. J Med Pest Control. 2010;26:393–95. (in Chinese). doi:10.3969/j.1003-6245.2010.05.001.
  • Chen J, Li JM, Zhang Y, Liu H, Gao L, Xu WT, et al. The analysis of disease burden of viral diarrhea cases in Tianjin during 2008-2009. J Trop Med. 2012;12:87–90. (in Chinese).
  • Tang YL, Dai YC, Nie J, Li JD, Huang BM. Epidemiology and genotype analysis of norovirus infection in children with acute diarrhea in Jiangmen. J Pract Med. 2011;27:2841–43. (in Chinese). doi:10.3969/j.1006-5725.2011.15.061.
  • Lu L, Zhong H, Xu M, Su L, Xu J. Genetic diversity and epidemiology of Genogroup II noroviruses in children with acute sporadic gastroenteritis in Shanghai, China, 2012–2017. BMC Infect Dis. 2019;19:736. doi:10.1186/s12879-019-4360-1.
  • Jin SY, Lin J, Xu XJ, Zhong DM. Genotypes and molecular characteristics of Norovirus from children with acute diarrhea in Hangzhou area from 2010 to 2011. Chin J Clin Lab Sci. 2012;30:924–26. (in Chinese). doi:10.13602/j.cnki.jcls.2012.11.028.
  • Chen Y, Zhou SF, Sun QL, Zhang F, Liang C, Zhang H, et al. Infection and genotypes of norovirus among children with acute diarrhea in sentinel hospitals in Hunan Province, 2012-2014. Pract Prev Med. 2016;23:773–76. (in Chinese). doi:10.3969/j.1006-3110.2016.07.002.
  • Yuan L, Pan XP, Liu GX, Yang WC. Analysis of viral diarrhea in children under 5 years old in Xining from 2015 to 2016. J Med Pest Control. 2018;34:147–50. (in Chinese). doi:10.7629/yxdwfz201802013.
  • Zeng M, Chen J, Gong S, Xu X, Zhu C, Zhu Q. Epidemiological surveillance of norovirus and rotavirus diarrhea among outpatient children in five metropolitan cities. Chin J Pediatr. 2010;48:564–70. (in Chinese). doi:10.3760/cma.J.0578-1310.2010.08.002.
  • Fang ZY, Xie HP, Lv HX, Zhang Q, Jiang X. Investigation of human calicivirus (HuCV) diarrhea among infantile and young children in China, 1999-2005. Chin J Virol. 2007;23:9–15. doi:10.1631/jzus.2007.B0900.
  • Liu P, Wang X, Lee JC, Teunis P, Hu S. Genetic susceptibility to norovirus GII.3 and GII.4 infections in Chinese pediatric diarrheal disease. Pediatr Infect Dis J. 2014;33:305–09. doi:10.1097/INF.0000000000000443.
  • Yan YX, Zhou YK, Zhang HF, Wang F, Jin M, Zhang Q, et al. Molecular epidemiology of norovirus infection among hospitalized children under 5 years with diarrhea in Lanzhou, 2015-2018. Int J Virol. 2020;027:53–56. (in Chinese). doi:10.3760/cma.j.1673-4092.2020.01.013.
  • Li X, Yang XD, Xu S, Wu DL, Sun LW, Shen B, et al. Detection of Norovirus genotype GII.4 Sydney 2012 variant from children under 5 years of age in Jilin Province, 2012-2013. Chin J Vaccines Immunization. 2015;21:283–88. (in Chinese).
  • Li X, Yang XD, Xu S, Wu DL, Sun LW, Lu X, et al. Epidemiological characteristics and genotype of Norovirus in Infants under 5 years old in Jilin Province in 2011. Chin J Vaccines Immunization. 2013;19:431–34. (in Chinese).
  • Kong XY. Molecular epidemiology of norovirus in some areas of China from 2011 to 2014. Chinese Center for Disease Control and Prevention; 2015. (in chinese).
  • Tan DM, Liu W, Deng LL. Molecular epidemiology of norovirus infection among sporadic cases of acute gastroenteritis in Nanning city. Chin J Public Health. 2011;27:1372–75. (in Chinese). doi:10.111/j.600-0714.2011.01024.x.
  • Chen LP, Ji L, Shen YH, Xu DS. Epidemic characteristics of norovirus in Huzhou during 2015-2017. Chin J Health Lab Tec. 2020;30:666–8+72. (in Chinese).
  • Xue CY, Pan LF, Zhu WP, Wang YP, Fu HQ, Cui CC, Lu L, Qiao S, Xu B. Molecular epidemiology of genogroup II norovirus infections in acute gastroenteritis patients during 2014-2016 in Pudong New Area, Shanghai, China. Gut Pathog. 2018;10:7. doi:10.1186/s13099-018-0233-1.
  • Li J, Zhang T, Xu JQ, Zhan JB, Guan XH, Xing XS, et al. Epidemic characteristics and genotypes of norovirus in Hubei Province, 2015. Chin J Dis Control Prev. 2017;349–52+61. (in Chinese). doi:10.16462/j.cnki.zhjbkz.2017.04.007.
  • Tian D, Liu GX, Qiong XU, Zhao SC, Zhang HY, Feng YL, et al. Analysis of the prevalence of norovirus genotypes in Qinghai Province from 2016 to 2017. J Pathogen Biol. 2018;13:1258–60. (in Chinese). doi:10.13350/j.cjpb.181117.
  • Nong H, Liu HH, Yang C, Yin LJ, Zhan XJ, Qin JQ. Results of norovirus detection of some diarrhea specimens in Nanning City, Guangxi Province. Mod Preventive Med. 2020;47:488–91. (in Chinese).
  • Zeng J, Wang Y, Bai P, Li R. Molecular epidemiology of Norovirus infection in Conghua, Guangzhou in 2011. Guang Dong Med J. 2013;34:549–51. (in Chinese). doi:10.3969/j.1001-9448.2013.04.017.
  • Shabiremu T, Xiaokelaiti N, Zhou HJ, Jin M, Kong XY, Zhou YK, et al. Molecular epidemiology of norovirus infection in hospitalized children with acute gastroenteritis in Urumqi, Xinjiang,2012-2014. Dis Surveillance. 2018;33:24–28. (in Chinese). doi:10.3784/j.1003-9961.2018.10.006.
  • Han YF, Gao J, Wei JJ, Deng T, Zhang JD, Tang WJ, et al. Surveillance results of rotavirus and norovirus diarrhea in Hanzhong, Shaanxi. China Trop Med. 2020;20:731–42. (in Chinese). doi:10.13604/j.cnki.46-1064/r.2020.08.08.
  • Dang W. Study on the pathogenic spectrum of viral diarrhea and the molecular epidemiology of norovirus in Ningxia from 2016 to 2018. Ningxia Medical University; 2019. (in Chinese).
  • Ying H, Shi YL, Kui Z, Jiang LL, Rong W, Li W, et al. Molecular epidemiological analysis of Norovirus in patients with foodborne diseases in sentinel hospital, Ma’anshan City, Anhui Province. Chin J Prev Med. 2019;53:581–85. (in Chinese). doi:10.3760/cma.j.0253-9624.2019.06.008.
  • Ren Y, Xu SJ, Zhang HL, Quan DF, Lai XL, Man YX, et al. Laboratory analysis of viral diarrhea pathogens in Longhua district, Shenzhen city from 2015 to 2017. J Trop Med. 2018;18:1346–50. (in Chinese).
  • Sun MH, Zhou XH, Xu PH, Xu JY. Monitoring and genotype analysis of the norovirus epidemic strains in Haiyan county in 2013. Chin J Health Lab Tec. 2015;025:2777–79. (in Chinese).
  • Shan BY, Li M, Pan JP, Chen N. Analysis of the etiology and epidemiological characteristics of viral diarrhea. J Pathogen Biol. 2018;9:1010–13. (in Chinese). doi:10.13350/j.cjpb.180918.
  • Ji L, Zhu YY, Chen LP, Shen YH, Wu XF, Xu DS. Infection status and genotype characteristics of GI norovirus in AGE/diarrhea cases in Huzhou, Zhejiang, 2017-2018. Dis Surveillance. 2019;34:536–40. (in Chinese). doi:10.3784/j.1003-9961.2019.06.014.
  • Li JY, Liu YB, Zhao YQ, Liu HS, Dong X. Monitoring results analysis of norovirus infected diarrhea in Shenyang from 2015 to 2017. Chin J Health Lab Tec. 2019;29:1884–5+9. (in Chinese).
  • Wang JH, Lin XP. Epidemiological study on viral diarrhea in Haikou City. J Prev Med Chin PLA. 2016;34:320. (in Chinese). doi:10.13704/j.cnki.jyyx.2016.s2.291.
  • Chen WP, Cui DW, Yang XZ, Zheng SF, Xie GL, Chen Y. Molecular epidemiological analysis of norovirus in patients with acute gastroenteritis in Zhejiang province during 2016. Chin J Clin Lab Sci. 2018;36:304–08. (in Chinese). doi:10.13602/j.cnki.jcls.2018.04.17.
  • Sang S, Zhao Z, Suo J, Xing Y, Jia N, Gao Y, et al. Study on the molecular epidemiological characteristics of norovirus in acute gastroenteritis of Beijing. Chin J Epidemiol. 2013;34:263. doi:10.3760/cma.j.0254-6450.2013.03.014.
  • Cai T, Yue LX, Zhang KY. Analysis of Norovirus detection in patients with Diarrhea in Dalian in 2013. Strait J Prev Med. 2015;21:38–39. (in Chinese).
  • Xin XY, Li XL, Zhang GH, Guo HF, Li YY. Analysis on epidemiological characteristics of norovirus infectious diarrhea, Taiyuan city,2015-2017. Preventive Med Tribune. 2019;361–64. (in Chinese). doi:10.16406/j.pmt.1672-9153.2019.05.015.
  • Chen C. Epidemiology and spatiotemporal dynamic of norovirus associated with sporadic acute gastroenteritis during 2013-2018, Zhoushan Islands, China. Nanchang University; 2019. (in Chinese).
  • Shi X, Shu C, Xu J, Leng Y. Analysis on the detection of norovirus and its genetic characteristics among patients with diarrhea in Heilongjiang Province from 2017 to 2019. Chin J PHM. 2020;36:457–9+98. (in Chinese). doi:10.19568/j.cnki.23-1318.2020.04.005.
  • Lei Y, Zhuang ZC, Tian H, Li XY. Molecular characteristics of norovirus in acute gastrointestinal illness, Tianjin, 2019. Dis Surveillance. 2020;35:913–19. (in Chinese). doi:10.3784/j.1003-9961.2020.10.011.
  • Xu JF, Xu H, Song YS, Xue Y, Shao SH, Shen HX. Molecular epidemiological characteristics and genotype analysis of norovirus in Zhenjiang region. Chin J Clin Lab Sci. 2017;35:857–60. (in Chinese). doi:10.1360/j.cnki.jcls.017.11.14.
  • Bai X, Zhang SH, Shen ZX. Analysis of Norovirus genotype in sporadic diarrhea cases in Hebei Province. Int J Virol. 2020;01:44–47. (in Chinese). doi:10.3760/cma.j.1673-4092.2020.01.011.
  • Xu J, Shi X, Shu C, Leng Y, Cao B, Wang KL. A study on molecular epidemiology of Norovirus in Heilongjiang province from 2012 to 2015. Chin J PHM. 2016;32:569–72+79. (in Chinese). doi:10.19568/j.cnki.23-1318.2016.05.001.
  • Yu J, Lai S, Wang X, Liao Q, Feng L, Ran L, et al. Analysis of epidemiology characteristics of norovirus among diarrheal outpatients in 27 provinces in China, 2009 – 2013. Chin J Epidemiol (Zhonghua Liu Xing Bing Xue Za Zhi). 2015;36:199–204. doi:10.3760/cma.j.0254-6450.2015.03.003.
  • Lin S, Pan H, Xiao W, Gong X, Kuang X, Teng Z, et al. Epidemiologic characteristics of Norovirus among adult patients with infectious diarrhea, in Shanghai, 2013-2018. Chin J Epidemiol. 2019;40:883–88. (in Chinese). doi:10.3760/cma.j.0254-6450.2019.08.003.
  • Yan Y, Wu Y, Guo J, Tian K, Wang D. Genotype features of Norovirus Associated With Acute Gastroenteritis Through Sentinel Surveillance in Guizhou Province, 2011. Chin J Virol. 2013;29:51–55. doi:10.13242/j.cnki.bingduxuebao.002351.
  • Yan Y, Guo J, Jiang WJ, Tian KC, Li SJ, Hu J, et al. A preliminary study on Norovirus variant for GII.4 in Guiyang regions. Chin J Microbiol Immunol. 2012;32:606–09. (in Chinese). doi:10.3760/cma.j.0254-5101.2012.07.008.
  • Burke RM, Shu-Man S, Catherine Y, Huang YC, Parashar UD, Lopman BA, et al. Burden of severe Norovirus disease in Taiwan, 2003-2013. Clin Infect Dis. 2018;9. doi:10.1093/cid/ciy298.
  • Liu TC, Kuo TY, Wu CY, Liao WT, Hall AJ, Wu FT. Recombinant GII.P16-GII.2 Norovirus, Taiwan, 2016. Emerg Infect Dis. 2017;23:1180. doi:10.3201/eid2307.170212.
  • Chan MCW, Leung TF, Chung TWS, Kwok AK, Nelson EAS, Lee N, et al. Virus Genotype distribution and virus burden in children and adults hospitalized for Norovirus gastroenteritis, 2012–2014, Hong Kong. Rep. 2015;5:11507. doi:10.1038/srep11507.
  • Cheung SKC, Kwok K, Zhang LY, Mohammad KN, Lui GCY, Lee N, Nelson EAS, Lai RWM, Leung TF, Chan PKS. Higher viral load of emerging Norovirus GII.P16-GII.2 than pandemic GII.4 and epidemic GII.17, Hong Kong, China. Emerg Infect Dis. 2018;25:119–22. doi:10.3201/eid2501.180395.
  • Jin M, Sun JL, Chang ZR, Li HY, Duan ZJ. Outbreaks of noroviral gastroenteritis and their molecular characteristics in China, 2006-2007. Chin J Epidemiol. 2010;31:549–53. doi:10.3760/cma.j.0254-6450.2010.05.017.
  • Shen JC, Liu YF, Li QJ, Xie HP, Jiang LY, Wu XW, et al. Norovirus infection and genotype in young children in Guangzhou, 2008 South China. J Med Pest Control. 2010;36:1–10. (in Chinese). doi:3969/j.1003-6245.2010.05.00.
  • Shen Z, Qian F, Li Y, Hu Y, Yuan Z, Zhang J. Novel Norovirus GII.4 Variant, Shanghai, China, 2012. Emerg Infect Dis. 2013;19:1337–39. doi:10.3201/eid1908.130026.
  • Zhang P, Chen LP, Fu Y, Ji L, Wu XF, Xu DS, Han J. Clinical and molecular analyses of norovirus-associated sporadic acute gastroenteritis: the emergence of GII.17 over GII.4, Huzhou, China, 2015. BMC Infect Dis. 2016;16:1–8. doi:10.1186/s12879-016-2033-x.
  • Hao SX, Xu H, Xue Y, Xu JF. Analysis on Norovirus infection and evolutionary recombination in 832 diarrhea samples of Zhenjiang area in 2015. Mod Preventive Med. 2017;44:4181–85. (in Chinese).
  • Jin M, Wu SY, Kong XY, Xie HP, Fu JG, He YQ, Feng W, Liu N, Li J, Rainey JJ. Norovirus outbreak surveillance, China, 2016–2018. Emerg Infect Dis. 2020;26(3):437–45. doi:10.3201/eid2603.191183.
  • Fu JG, Bao CJ, Huo X, Hu JL, Shi C, Lin Q, Zhang J, Ai J, Xing Z. Increasing recombinant strains emerged in Norovirus outbreaks in Jiangsu, China: 2015–2018. Sci Rep. 2019;9:20012. doi:10.1038/s41598-019-56544-2.
  • Gao ZY, Liu BW, Yan HQ, Li WH, Jia L, Tian Y, Chen Y, Wang Q, Pang X. Norovirus outbreaks in Beijing, China, from 2014 to 2017. J Infect. 2019;79:159–66. doi:10.1016/j.jinf.2019.05.019.
  • Chen HL, Qian FX, Xu J, Chan M, Shen Z, Zai SB, Shan M, Cai J, Zhang W, He J. A novel norovirus GII.17 lineage contributed to adult gastroenteritis in Shanghai, China, during the winter of 2014–2015. Emerging Microbes Infect. 2015;4(1):e67. doi:10.1038/emi.2015.67.
  • Chan MCW, Lee N, Hung TN, Kwok K, Cheung K, Tin EKY, Lai RWM, Nelson EAS, Leung TF, Chan PKS, et al. Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014. Nat Commun. 2015;6:10061. doi:10.1038/ncomms10061.
  • Lu J, Lm S, Fang L, Yang F, Mo YL, Lao JQ, Zheng H, Tan X, Lin H, Rutherford S, et al. Gastroenteritis outbreaks caused by Norovirus GII.17, Guangdong Province, China, 2014-2015. Emerg Infect Dis. 2015;21:1240–42. doi:10.3201/eid2107.150226.
  • Fu J, Ai J, Jin M, Jiang C, Zhu Y. Emergence of a new GII.17 norovirus variant in patients with acute gastroenteritis in Jiangsu, China, September 2014 to March 2015. Eur Communicable Dis Bull. 2015;20:21157. doi:10.2807/1560-7917.ES2015.20.24.
  • Wu W, Zhang HB, Zhang HL, Yang H, He YQ. The genotype of norovirus in Shenzhen, 2010. Chin J Virol. 2012;28:219–23. (in Chinese). doi:10.13242/j.cnki.bingduxuebao.002269.
  • Tu LT, Liu FP, Huang YC, Huang CG, Yang S, Tsao KC, Lai M-W, Chen C-J. Genetic susceptibility to Norovirus GII.4 Sydney Strain infections in Taiwanese children. Pediatr Infect Dis J. 2017;36:353–57. doi:10.1097/INF.0000000000001446.
  • Song SL, Wei T, Zhang XH. Molecular characteristics of norovirus responsible for diarrhea outbreaks in Yuhang district of Hangzhou,2006-2007. Chin J Prev Med. 2010;11:225–27. (in Chinese). doi:10.16506/j.1009-6639.2010.03.006.
  • Luan MC, Liu YL, Lang XY, Yu L, Bo ZJ. Genetic characteristics of noroviruses from foodborne diarrhea in Dalian. Chin J Microecol. 2018;30:1313–16. (in Chinese). doi:10.13381/j.cnki.cjm.201811018.
  • Yao X, Jiang XH, Chen LL, Zhang CL, Xie NH. Genotype analysis of acute gastroenteritis outbreaks by norovirus in Fuzhou city of China. Chin J Viral Dis. 2020;10:1–5. (in Chinese). doi:10.16505/j.2095-0136.2019.0072.
  • Han JK, Wu XF, Chen LP, Fu Y, Xu DS, Zhang P, Ji L. Emergence of norovirus GII.P16-GII.2 strains in patients with acute gastroenteritis in Huzhou, China, 2016–2017. BMC Infect Dis. 2018;18:342. doi:10.1186/s12879-018-3259-6.
  • Wang X, Yong W, Du XF, Zhang Z, He M, Qiao M, et al. Molecular epidemiology of Norovirus outbreaks in Nanjing,China,2014-2017. Chin J Virol. 2018;04:483–90. (in Chinese). doi:10.13242/j.cnki.bingduxuebao.003393.
  • Cheng Y, Meng JT, Zhang XC, Huang WW, Chen ZH, Li GY, et al. Prevalence of Norovirus genotypes in Chengdu. J Preventive Med Inform. 2018;34:1294–97. (in Chinese).
  • Zhang J, Chang ZR, Sun JL, Liao QH, Xing WJ, Liu FF. Infectious diarrhea epidemics caused by norovirus and its control strategy in China. Dis Surveillance. 2014;29:516–21. (in Chinese). doi:10.3784/j.1003-9961.2014.07.004.
  • Lian YY. The epidemic characteristics and transmission risk factors of norovirus outbreaks reprorted to the National Public Health Emergency Management Information System in China from 2014-2018. Chinese Center for Disease Control and Prevention; 2019. (in Chinese).
  • Ao YY, Wang JJ, Hua L, He YQ, Dong XG, Xuan W, Peng J, Zhang H, Jin M, Duan Z. Norovirus GII.P16/GII.2–associated gastroenteritis, China, 2016. Emerg Infect Dis. 2017;23:1172–75. doi:10.3201/eid2307.170034.
  • Ao YY, Xie XL, Dong XG, Jin M, Duan ZJ. Genetic analysis of an emerging GII.P2–GII.2 Norovirus associated with a 2016 outbreak of acute gastroenteritis in China. Virol Sin. 2019;34:111–14. doi:10.1007/s12250-019-00084-6.
  • Tohma K, Lepore CJ, Ford-Siltz LA, Parra GI, Duprex WP. Phylogenetic analyses suggest that factors other than the capsid protein play a role in the epidemic potential of GII.2 Norovirus. Msphere. 2017;2:e00187–17. doi:10.1128/mSphereDirect.-17.
  • Iritani N, Kaida A, Abe N, Sekiguchi J, Kubo H, Takakura KI, Goto K, Ogura H, Seto Y. Increase of GII.2 norovirus infections during the 2009–2010 season in Osaka City, Japan. J Med Virol. 2012;84:517–25. doi:10.1002/jmv.23211.
  • Lun J, Hewitt J, Yan G, Enosi Tuipulotu D, William R, White P. Recombinant GII.P16/GII.4 Sydney 2012 was the dominant Norovirus identified in Australia and New Zealand in 2017. Viruses. 2018;10:548. doi:10.3390/v10100548.
  • Waters A, Coughlan S, Hall WW. Characterisation of a novel recombination event in the norovirus polymerase gene. VIROLOGY. 2007;363:11–14. doi:10.1016/j.virol.2007.03.012.
  • Worobey M, Holmes EC. Evolutionary aspects of recombination in RNA viruses. J Gen Virol. 1999;80:2535–43. doi:10.1099/0022-1317-80-10-2535.
  • Bull RA, Hansman GS, Clancy LE, Tanaka MM, White PA. Norovirus recombination in ORF1/ORF2 overlap. Emerg Infect Dis. 2005;11:1079–85. doi:10.3201/eid1107.041273.
  • Bull RA, Tanaka MM, White PA. Norovirus recombination. J Gen Virol. 2008;88:3347–59. doi:10.1099/vir.0.83321-0.
  • Miller WA, Dreher TW, Hall TC. Synthesis of brome mosaic virus subgenomic RNA in vitro by internal initiation on (−)-sense genomic RNA. Nature. 1985;313:68–70. doi:10.1038/313068a0.
  • Graaf MD, Beek JV, Koopmans MPG. Human norovirus transmission and evolution in a changing world. Nat Rev Microbiol. 2016;14:421–33. doi:10.1038/nrmicro.2016.48.
  • Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. The potential economic value of a human norovirus vaccine for the United States. Vaccine. 2012;30:7097–104. doi:10.1016/j.vaccine.2012.09.040.
  • Tan M, Huang P, Xia M, Fang PA, Zhong W, Mcneal M, Wei C, Jiang W, Jiang X. Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol. 2011;85:753–64. doi:10.1128/JVI.01835-10.
  • Xia M, Wei C, Wang L, Cao D, Meng XJ, Jiang X, Tan M. A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus. Vaccine. 2016;34:905–13. doi:10.1016/j.vaccine.2015.12.068.
  • Tan M, Fang P, Chachiyo T, Xia M, Huang P, Fang Z, Jiang W, Jiang X. Noroviral P particle: structure, function and applications in virus-host interaction. Virology. 2008;382:115–23. doi:10.1016/j.virol.2008.08.047.
  • Verma V, Tan W, Puth S, Cho K, Lee E. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB. Transl Med. 2016;14:135. doi:10.1186/s967-016-0899-4.
  • Xia M, Tan M, Wei C, Zhong W, Wang L, Mcneal M, Jiang X. A candidate dual vaccine against influenza and noroviruses. Vaccine. 2011;29:7670–77. doi:10.1016/j.vaccine.2011.07.139.
  • Wang L, Cao D, Wei C, Meng X, Jiang X, Tan M. A dual vaccine candidate against norovirus and hepatitis E virus. Vaccine. 2014;32(4):445–52. doi:10.1016/j.vaccine.2013.11.064.
  • Jiang L, Fan R, Sun S, Fan P, Su W, Gao F, Gao F, Xu F, Kong W, Jiang C. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice. Vaccine. 2015;33:6596–603. doi:10.1016/j.vaccine.2015.10.104.
  • Yu Y, Fu L, Shi Y, Guan S, Yang L, Gong X, Yin H, He X, Liu D, Kuai Z, et al. Elicitation of HIV-1 neutralizing antibodies by presentation of 4E10 and 10E8 epitopes on Norovirus P particles. Immunol Lett. 2015;168(2):271–78. doi:10.1016/j.imlet.2015.10.003.
  • Dai Y, Xia M, Huang Q, Tan M, Lin Q, Zhuang Y, Long Y, Li J-D, Jiang X, Zhang X-F, et al. Characterization of antigenic relatedness between GII.4 and GII.17 Noroviruses by use of serum samples from Norovirus-infected patients. J Clin Microbiol. 2017;55:3366–73. doi:10.1128/JCM.00865-17.
  • Malm M, Tamminen K, Lappalainen S, Uusi-Kerttula H, Vesikari T, Blazevic V. Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition. Clin Vaccine Immunol. 2015;22(6):656–63. doi:10.1128/CVI.00015-15.
  • Malm M, Tamminen K, Timo V, Blazevic V. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Anti-gens and Cross-React with Genogroup II-Specific Mouse Sera. Viral Immunol. 2018;31:649–57. doi:10.1089/vim.2018.0115.
  • Czakó R, Atmar R, Opekun AR, Gilger M, Graham D, Estes M, Hodinka RL. Experimental human infection with Norwalk virus elicits a surrogate neutralizing anti-body response with cross-genogroup activity. Clin Vaccine Immunol. 2015;22:221–28. doi:10.1128/CVI.00516-14.
  • Han Z, Zhang X, Liu Z, Zhang H, Tang F, Li Q. Cross-blockade antibody spectrum of predominant genotypes of norovirus. Chin J Biologi-cals. 2019;32:1316–21. (in Chinse). doi:10.13200/j.cnki.cjb.002907.
  • Son H, Jeong H, Cho M, Lee J, Cheon D, Yoon K, Jeong A-Y, Jung S, Kim K, Cheon D-S. Seroepidemiology of predominant Norovirus strains circulating in Korea by using recombinant virus-like particle antigens. Foodborne Pathog Dis. 2013;10:461–66. doi:10.1089/fpd.2012.1300.
  • Tamminen K, Lappalainen S, Huhti L, Vesikari T, Blazevic V. Trivalent combination vaccine induces broad heterologous im-mune responses to norovirus and rotavirus in mice. PLoS ONE. 2013;08:e70409. doi:10.1371/journal.pone.0070409.
  • Blazevic V, Lappalainen S, Nurminen K, Huhti L, Vesikari T. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. Vaccine. 2011;29:8126–33. doi:10.1016/j.vaccine.2011.08.026.
  • Malm M, Diessner A, Tamminen K, Liebscher M, Vesikari T, Blazevic V. Rotavirus VP6 as an adjuvant for bivalent Norovirus vaccine produced in Nicotiana benthamiana. Pharmaceutics. 2019;11:229. doi:10.3390/pharmaceutics11050229.
  • Tamminen K, Huhti L, Koho T, Lappalainen S, Blazevic V, Vesikari T, Blazevic V. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles. Immunology. 2011;135:89–99. doi:10.1111/j.365-2567.011.03516.x.
  • Mai H, Gao Y, Cong X, Wang H, Liu N, Huang XJ, Xu L, Chen Y, Wei L. GII.4 Sydney_2012 norovirus infection in immunocompromised patients in Beijing and its rapid evolution in vivo. J Med Virol. 2016;88(2):224–33. doi:10.1002/jmv.24332.
  • Lindesmith LC, Donaldson EF, Baric RS. Norovirus GII.4 Strain Antigenic Variation. J Virol. 2011;85:231–42. doi:10.1128/JVI.01364-10.
  • Cao MC, Li XX, He J. Researches on prevalence and molecular evolution of norovirus GII.17: an overview. Chin J Public Health. 2018;34:134–36. (in Chinese). doi:10.11847/zgggws1118316.
  • Dong XG, Qin M, Wang ZE, Yang XX, Wu QR, Feng HR, Wei X, Yu H, Li J, Li J. Should we pay attention to recombinant norovirus strain GII.P7/GII.6? J Infect Public Heal. 2019;12:403–09. doi:10.1016/j.jiph.2018.12.007.
  • Zhu L, Tong JX, Yao XL, Deng XQ, Lu Y. Analysis of norovirus detection of patients with acute gastroenteritis in Fushun from 2017 to 2019. Chin Front Health Quarantine. 2020;43:337–39. (in Chinese). doi:10.16408/j.1004-9770.2020.05.011.
  • Dai YC. Evolution mechanism of major epidemic norovirus GII.4 strain and passive immunization based on P Particle. Southern Medical University; 2013. (in Chinese).
  • Swanstrom J, Lindesmith LC, Donaldson EF, Yount B, Baric RS. Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects. J Virol. 2014;88(2):829–37. doi:10.1128/JVI.02793-13.
  • Tan M, Jiang X, Madhani HD. Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS Pathog. 2010;6:e1000983. doi:10.1371/journal.ppat.1000983.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.